Physician profile
William A Thomas
NPI 1700825569
$5,131.65
in general payments reported to CMS, 2019-2025
37 companies · $790 in 2025
The $790 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $188 · 2021: $836 · 2022: $1,175 · 2023: $565 · 2024: $699 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,054.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,197.30 | 2021-2025 | Qulipta, Ubrelvy |
| Lilly USA, LLC | $411.38 | 2019-2025 | Kisunla, Reyvow, Emgality |
| Biohaven Pharmaceutical Holding Company LTD. | $360.91 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $340.37 | 2021 | |
| Ucb, INC. | $271.57 | 2019-2025 | Rystiggo |
| Lundbeck LLC | $230.67 | 2019-2025 | Vyepti |
| Eisai INC. | $219.68 | 2019-2025 | |
| Amgen INC. | $211.47 | 2019-2024 | Uplizna |
| Pfizer INC. | $192.05 | 2023-2025 | |
| Amneal Pharmaceuticals LLC | $147.57 | 2019-2024 | Rytary |
| Boston Scientific Corporation | $146.27 | 2025 | General - Angiography |
| Horizon Therapeutics Plc | $124.10 | 2022-2023 | Uplizna |
| Neurocrine Biosciences, INC. | $103.93 | 2019-2025 | Ingrezza |
| Sunovion Pharmaceuticals INC. | $100.95 | 2019-2020 | |
| Neurelis, INC. | $91.99 | 2024-2025 | Valtoco |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $91.94 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $91.08 | 2019-2025 | Austedo Xr |
| Celgene Corporation | $80.01 | 2021-2022 | |
| Genentech USA, INC. | $65.09 | 2022-2025 | Ocrevus Zunovo |
| Acorda Therapeutics, INC | $65.01 | 2019 | |
| Adamas Pharmaceuticals, INC. | $64.32 | 2019 | |
| Supernus Pharmaceuticals, INC. | $60.80 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $54.45 | 2019 | |
| Avanir Pharmaceuticals, INC. | $48.59 | 2019 | |
| Biogen, INC. | $47.79 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $41.70 | 2022 | |
| Kyowa Kirin, INC. | $38.99 | 2024 | Nourianz |
| Upsher-Smith Laboratories LLC | $35.13 | 2021 | |
| Sumitomo Pharma America, INC. | $33.46 | 2023 | Aptiom |
| Medtronic USA, INC. | $26.22 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $25.62 | 2021 | |
| Genzyme Corporation | $23.48 | 2019 | |
| W. L. Gore & Associates, INC. | $19.56 | 2025 | Gore Synecor Biomaterial |
| Emd Serono, INC. | $19.01 | 2024 | |
| Acadia Pharmaceuticals INC | $18.10 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.50 | 2023 | Rexulti |
| Livanova USA, INC. | $14.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.